Assessment of Filled Buprenorphine Prescriptions for Opioid Use Disorder During the Coronavirus Disease 2019 Pandemic
- PMID: 33346795
- PMCID: PMC7754073
- DOI: 10.1001/jamainternmed.2020.7497
Assessment of Filled Buprenorphine Prescriptions for Opioid Use Disorder During the Coronavirus Disease 2019 Pandemic
Abstract
This cohort study examines changes in the number of buprenorphine prescriptions fill by individuals with opioid use disorder before and during the coronavirus disease 2019 pandemic.
Conflict of interest statement
Figures

Comment in
-
Buprenorphine Opioid Treatment During the COVID-19 Pandemic.JAMA Intern Med. 2021 Aug 1;181(8):1135. doi: 10.1001/jamainternmed.2021.0777. JAMA Intern Med. 2021. PMID: 33843962 No abstract available.
Similar articles
-
Concentration of Patient Care Among Buprenorphine-Prescribing Clinicians in the US.JAMA. 2021 Jun 1;325(21):2206-2208. doi: 10.1001/jama.2021.4469. JAMA. 2021. PMID: 34061152 Free PMC article.
-
Datapoints: regional variation in benzodiazepine prescribing for patients on opioid agonist therapy.Psychiatr Serv. 2014 Jan 1;65(1):4. doi: 10.1176/appi.ps.650308. Psychiatr Serv. 2014. PMID: 24382761 Free PMC article. No abstract available.
-
Early-Career and Graduating Physicians More Likely to Prescribe Buprenorphine.J Am Board Fam Med. 2020 Jan-Feb;33(1):7-8. doi: 10.3122/jabfm.2020.01.190230. J Am Board Fam Med. 2020. PMID: 31907240
-
Buprenorphine Prescribing: To Expand or Not to Expand.J Psychiatr Pract. 2016 May;22(3):183-92. doi: 10.1097/PRA.0000000000000154. J Psychiatr Pract. 2016. PMID: 27123798 Free PMC article. Review.
-
Managing opioid addiction with buprenorphine.Am Fam Physician. 2006 May 1;73(9):1573-8. Am Fam Physician. 2006. PMID: 16719249 Review.
Cited by
-
Trends in Opioid Use Disorder Outpatient Treatment and Telehealth Utilization Before and During the COVID-19 Pandemic.Psychiatr Serv. 2024 Jan 1;75(1):72-75. doi: 10.1176/appi.ps.20230102. Epub 2023 Jul 18. Psychiatr Serv. 2024. PMID: 37461819 Free PMC article.
-
Substitution of Nonpharmacologic Therapy With Opioid Prescribing for Pain During the COVID-19 Pandemic.JAMA Netw Open. 2021 Dec 1;4(12):e2138453. doi: 10.1001/jamanetworkopen.2021.38453. JAMA Netw Open. 2021. PMID: 34889946 Free PMC article.
-
Use of buprenorphine for those with employer-sponsored insurance during the initial phase of the COVID-19 pandemic.J Subst Abuse Treat. 2021 Oct;129:108384. doi: 10.1016/j.jsat.2021.108384. Epub 2021 Apr 8. J Subst Abuse Treat. 2021. PMID: 34080552 Free PMC article. Review.
-
Assessment of State and Federal Health Policies for Opioid Use Disorder Treatment During the COVID-19 Pandemic and Beyond.JAMA Health Forum. 2021 Nov;2(11):e213833. doi: 10.1001/jamahealthforum.2021.3833. Epub 2021 Nov 19. JAMA Health Forum. 2021. PMID: 35647581 Free PMC article. Review.
-
Federal Impacts on Buprenorphine Prescribing in Washington State, 2012 to 2022.Am J Public Health. 2024 Jul;114(7):696-704. doi: 10.2105/AJPH.2024.307649. Epub 2024 May 2. Am J Public Health. 2024. PMID: 38696736 Free PMC article.
References
-
- Ahmad FB, Rossen LM SP. Provisional drug overdose death counts. National Center for Health Statistics. Reviewed September 16, 2020. Accessed October 10, 2020. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm
-
- American Society of Addiction Medicine . Access to buprenorphine in office-based settings: ASAM COVID-19 Task Force Recommendations. Published 2020. Accessed October 10, 2020. https://www.asam.org/Quality-Science/covid-19-coronavirus/access-to-bupr...
-
- Centers for Disease Control and Prevention . Data resources: analyzing opioid prescription data and oral morphine milligram equivalents (MME), 2018. version. Reviewed October 9, 2020. Accessed January 8, 2020. https://www.cdc.gov/drugoverdose/resources/data.html
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical